Use of EP2 selective receptor agonists in medical treatment

Provided is the use of a prostaglandin E2 receptor subtype EP2 selective receptor agonist compound belonging to a specified class of compounds in the manufacture of a medicament for treating avascular necrosis, including use of the compound (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-met...

Full description

Saved in:
Bibliographic Details
Main Authors MACLEAN, DAVID BURTON, KESHARY, PRAKASH RAJ, THOMPSON, DAVID DUANE, WRIGHT, TIMOTHY MICHAEL, PARALKAR, VISHWAS MADHAV, CONSTAN, ALEXANDER ANGELO, ROMAN, DOINA COSMA
Format Patent
LanguageEnglish
Published 30.06.2008
Edition7
Subjects
Online AccessGet full text

Cover

Loading…